Mean platelet volume and platelet distribution width in vascular dementia and Alzheimer’s disease

References

• de la Torre JC. Vascular risk factor detection and control may prevent Alzheimer’s disease. Ageing Res Rev 2010;9:218–225
   PubMed Web of Science ®Google Scholar
• Haag MD, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM. Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry 2009;80:13–17
   PubMed Web of Science ®Google Scholar
• Borroni B, Agosti C, Marcello E, Di LM, Padovani A. Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets. Exp Gerontol 2010;45:53–56
   PubMed Web of Science ®Google Scholar
• Farias G, Perez P, Slachevsky A, Maccioni RB. Platelet tau pattern correlates with cognitive status in Alzheimer’s disease. J Alzheimers Dis 2012;31:65–69
   PubMed Web of Science ®Google Scholar
• Forlenza OV, Wacker P, Nunes PV, Yacubian J, Castro CC, Otaduy MC, Gattaz WF. Reduced phospholipid breakdown in Alzheimer’s brains: A 31P spectroscopy study. Psychopharmacology (Berl) 2005;180:359–365
   PubMed Web of Science ®Google Scholar
• Johnston JA, Liu WW, Coulson DT, Todd S, Murphy S, Brennan S, Foy CJ, Craig D, Irvine GB, Passmore AP. Platelet beta-secretase activity is increased in Alzheimer’s disease. Neurobiol Aging 2008;29:661–668
   PubMed Web of Science ®Google Scholar
• Forlenza OV, Torres CA, Talib LL, de Paula VJ, Joaquim HP, Diniz BS, Gattaz WF. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer’s disease. J Psychiatr Res 2011;45:220–224
   PubMed Web of Science ®Google Scholar
• Stellos K, Katsiki N, Tatsidou P, Bigalke B, Laske C. Association of platelet activation with vascular cognitive impairment: Implications in dementia development. Curr Vasc Pharmacol 2012;10:1–3
   Google Scholar
• Laske C, Sopova K, Stellos K. Platelet activation in Alzheimer’s disease: From pathophysiology to clinical value. Curr Vasc Pharmacol 2012;10:626–630
   PubMed Web of Science ®Google Scholar
• Purandare N, Burns A. Cerebral emboli in the genesis of dementia. J Neurol Sci 2009;283:17–20
   PubMedGoogle Scholar
• Purandare N, Burns A, Morris J, Perry EP, Wren J, McCollum C. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer’s disease and vascular dementia. Am J Psychiatry 2012;169:300–308
   PubMed Web of Science ®Google Scholar
• Sakurai H, Hanyu H, Sato T, Kume K, Hirao K, Kanetaka H, Iwamoto T. Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer’s disease and cerebrovascular disease: A pilot study. Geriatr Gerontol Int 2013;13:90–97
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation. Curr Pharm Des 2011;17:47–58
   PubMed Web of Science ®Google Scholar
• Kaito K, Otsubo H, Usui N, Yoshida M, Tanno J, Kurihara E, Matsumoto K, Hirata R, Domitsu K, Kobayashi M. Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. Br J Haematol 2005;128:698–702
   PubMed Web of Science ®Google Scholar
• Wang RT, Li Y, Zhu XY, Zhang YN. Increased mean platelet volume is associated with arterial stiffness. Platelets 2011;22:447–451
   PubMed Web of Science ®Google Scholar
• Jans DM, Martinet W, Van De Parre TJ, Herman AG, Bult H, Kockx MM, De Meyer GR. Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer’s disease. Cardiovasc Hematol Disord Drug Targets 2006;6:21–34
   PubMedGoogle Scholar
• Prodan CI, Ross ED, Stoner JA, Cowan LD, Vincent AS, Dale GL. Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease. Neurology 2011;76:247–252
   PubMed Web of Science ®Google Scholar
• Prodan CI, Szasz R, Vincent AS, Ross ED, Dale GL. Coated-platelets retain amyloid precursor protein on their surface. Platelets 2006;17:56–60
   PubMed Web of Science ®Google Scholar
• Prodan CI, Ross ED, Vincent AS, Dale GL. Differences in coated-platelet production between frontotemporal dementia and Alzheimer disease. Alzheimer Dis Assoc Disord 2009;23:234–237
   PubMed Web of Science ®Google Scholar
• Prodan CI, Ross ED, Vincent AS, Dale GL. Coated-platelets correlate with disease progression in Alzheimer disease. J Neurol 2007;254:548–549
   PubMed Web of Science ®Google Scholar
• Prodan CI, Ross ED, Vincent AS, Dale GL. Rate of progression in Alzheimer’s disease correlates with coated-platelet levels – a longitudinal study. Transl Res 2008;152:99–102
   PubMed Web of Science ®Google Scholar
• Salmina AB, Inzhutova AI, Malinovskaya NA, Petrova MM. Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: neuronal and glial control. J Alzheimers Dis 2010;22:17–36
   PubMed Web of Science ®Google Scholar
• Gattaz WF, Cairns NJ, Levy R, Forstl H, Braus DF, Maras A. Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer’s disease. Eur Arch Psychiatry Clin Neurosci 1996;246:129–131
   PubMed Web of Science ®Google Scholar
• Krzystanek E, Krzystanek M, Opala G, Trzeciak HI, Siuda J, Malecki A. Platelet phospholipase A2 activity in patients with Alzheimer’s disease, vascular dementia and ischemic stroke. J Neural Transm 2007;114:1033–1039
   PubMed Web of Science ®Google Scholar
• Emmerling MR, Moore CJ, Doyle PD, Carroll RT, Davis RE. Phospholipase A2 activation influences the processing and secretion of the amyloid precursor protein. Biochem Biophys Res Commun 1993;197:292–297
   PubMed Web of Science ®Google Scholar
• Borkataky S, Jain R, Gupta R, Singh S, Krishan G, Gupta K, Kudesia M. Role of platelet volume indices in the differential diagnosis of thrombocytopenia: A simple and inexpensive method. Hematology 2009;14:182–186
   PubMed Web of Science ®Google Scholar
• Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010;330:841–845
   PubMed Web of Science ®Google Scholar
• Boche D, Nicoll JA. The role of the immune system in clearance of Abeta from the brain. Brain Pathol 2008;18:267–278
   PubMed Web of Science ®Google Scholar
• Kaushansky K. Thrombopoietin. N Engl J Med 1998;339:746–754
   PubMed Web of Science ®Google Scholar
• Gomez RM, Moscato P. Identification of a 5-protein biomarker molecular signature for predicting Alzheimer’s disease. PLoS One 2008;3:e3111 . doi:10.1371/journal.pone.0003111
   Web of Science ®Google Scholar
• Lampron A, Gosselin D, Rivest S. Targeting the hematopoietic system for the treatment of Alzheimer’s disease. Brain Behav Immun 2011;25(Suppl 1):S71–S79
   Google Scholar
• Wang RT, Jin D, Li Y, Liang QC. Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer’s disease. J Psychiatr Res 2013;47:644–649
   PubMed Web of Science ®Google Scholar
• Liu R, Gao F, Huo J, Yi Q. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease. Platelets 2012;23:11–16
   PubMed Web of Science ®Google Scholar